Lobbying

Valyrian Smoke's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medical/Disease Research/Clinical Labs.

Valyrian Smoke

Latest quarter
$0
Q2 2026 · 1 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q2 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Valyrian Smoke lobbying by quarter
Valyrian Smoke lobbying by quarter
QuarterAmountReports
Q4 2022$40K1
Q1 2023$12.5K1
Q2 2023$01
Q3 2023$01
Q4 2023$01
Q1 2024$01
Q2 2024$01
Q3 2024$01
Q4 2024$01
Q1 2025$01
Q2 2025$01
Q3 2025$01
Q4 2025$01
Q1 2026$01
Q2 2026$01

Policy issues the reports name

  • Health issues1 reports
  • Medical research and clinical labs1 reports
  • Veterans1 reports

A report that names several issues counts once for each.

Who was lobbied

  • HOUSE OF REPRESENTATIVES1 reports
  • SENATE1 reports

Firms it paid

Firm
Bluestone Strategies$52.5K15 quarters

Former officials lobbying for it

Former position
BEHRENDS FOSTERChief of Staff, Representative Dave CampQ4 2022

Lobbying reports

Filed by
07/20for Q2Bluestone StrategiesUnder $5,000
05/06for Q1Bluestone StrategiesUnder $5,000
01/20for Q4 2025Bluestone StrategiesUnder $5,000
25/10/20for Q3 2025Bluestone StrategiesUnder $5,000
25/07/21for Q2 2025Bluestone StrategiesUnder $5,000
25/04/21for Q1 2025Bluestone StrategiesUnder $5,000
25/01/21for Q4 2024Bluestone StrategiesUnder $5,000
24/10/21for Q3 2024Bluestone StrategiesUnder $5,000
24/07/22for Q2 2024Bluestone StrategiesUnder $5,000
24/04/22for Q1 2024Bluestone StrategiesUnder $5,000
23/12/29for Q4 2023Bluestone StrategiesUnder $5,000
23/10/20for Q3 2023Bluestone StrategiesUnder $5,000
23/08/04for Q2 2023Bluestone StrategiesUnder $5,000
23/04/19for Q1 2023Bluestone Strategies$12.5K
23/01/14for Q4 2022Bluestone Strategies$40K